^
Association details:
Biomarker:No biomarker
Cancer:Multiple Myeloma
Drug:Venclexta (venetoclax) (Bcl2 inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Multiple Myeloma: Useful In Certain Circumstances…Venetoclax/dexamethasone only for t(11;14) patients